Although in many areas those overlaps did not give rise to competition problems in others there were three markets where the merged entity, to be called Pfizer Inc, would have achieved very high market shares.
Alors que ces chevauchements ne posaient aucun problème de concurrence pour de nombreux domaines, la nouvelle société, qui doit s'appeler Pfizer Inc, aurait atteint des parts de marché très élevées sur trois marchés.
